Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1511)
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
3,418
Price
$75.86
Total Value
$259.29K
Shares Held After
1,152,987
% of Holdings
0.3%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,219
Price
$74.83
Total Value
$615.03K
Shares Held After
1,156,405
% of Holdings
0.7%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
8,363
Price
$74.29
Total Value
$621.29K
Shares Held After
1,164,624
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
3,057
Price
$225.00
Total Value
$687.83K
Shares Held After
21,010
% of Holdings
12.7%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
341
Price
$300.00
Total Value
$102.30K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
129,672
Price
$19.52
Total Value
$2.53M
Shares Held After
4,644,386
% of Holdings
2.7%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$19.35
Total Value
$38.70K
Shares Held After
13,500
% of Holdings
14.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,633
Price
$498.42
Total Value
$1.31M
Shares Held After
12,489
% of Holdings
17.4%
ONCOLYTICS BIOTECH INC (ONCY)
Parsons James T. — Director
Shares
10,000
Price
$1.03
Total Value
$10.30K
Shares Held After
41,849
% of Holdings
23.9%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Guyer Charles Greg — EVP, Chief Technical Officer
Shares
16,486
Price
$60.46
Total Value
$996.74K
Shares Held After
79,953
% of Holdings
17.1%
CRISPR Therapeutics AG (CRSP)
KASINGER JAMES R. — General Counsel and Secretary
Shares
2,800
Price
$52.80
Total Value
$147.84K
Shares Held After
87,815
% of Holdings
3.1%
CRISPR Therapeutics AG (CRSP)
Kulkarni Samarth — Director
Shares
9,798
Price
$52.80
Total Value
$517.33K
Shares Held After
235,558
% of Holdings
4.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
1,067
Price
$19.08
Total Value
$20.36K
Shares Held After
1,109,905
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
LANGE LOUIS G — Director
Shares
446
Price
$31.23
Total Value
$13.93K
Shares Held After
10,360
% of Holdings
4.1%
NewAmsterdam Pharma Co N.V. (NAMS)
LANGE LOUIS G — Director
Shares
44,173
Price
$30.41
Total Value
$1.34M
Shares Held After
10,806
% of Holdings
80.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$21.55
Total Value
$21.55K
Shares Held After
38,415
% of Holdings
2.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
11,111
Price
$83.72
Total Value
$930.21K
Shares Held After
68,052
% of Holdings
14.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
12,882
Price
$83.10
Total Value
$1.07M
Shares Held After
79,163
% of Holdings
14.0%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,765
Price
$82.13
Total Value
$144.96K
Shares Held After
92,045
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$544.76
Total Value
$163.43K
Shares Held After
130
% of Holdings
69.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,160
Price
$544.20
Total Value
$631.28K
Shares Held After
430
% of Holdings
73.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$543.04
Total Value
$130.33K
Shares Held After
1,590
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,178
Price
$542.13
Total Value
$638.63K
Shares Held After
1,830
% of Holdings
39.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
942
Price
$541.04
Total Value
$509.66K
Shares Held After
3,008
% of Holdings
23.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$540.07
Total Value
$453.66K
Shares Held After
3,950
% of Holdings
17.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,095
Price
$538.92
Total Value
$590.12K
Shares Held After
4,790
% of Holdings
18.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,106
Price
$538.01
Total Value
$595.04K
Shares Held After
5,885
% of Holdings
15.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$536.95
Total Value
$652.39K
Shares Held After
6,991
% of Holdings
14.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$535.82
Total Value
$441.51K
Shares Held After
8,206
% of Holdings
9.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$533.47
Total Value
$128.03K
Shares Held After
9,030
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$532.13
Total Value
$191.57K
Shares Held After
9,270
% of Holdings
3.7%
Vaxcyte, Inc. (PCVX)
Cowan Elvia — SVP, Finance & CAO
Shares
2,500
Price
$58.59
Total Value
$146.48K
Shares Held After
30,867
% of Holdings
7.5%
Korro Bio, Inc. (KRRO)
BASKETT FOREST — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Chang Carmen — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Florence Anthony A. Jr. — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Yang Rick — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
New Enterprise Associates 17, L.P. — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
SANDELL SCOTT D — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Korro Bio, Inc. (KRRO)
Mathers Edward T — 10% Owner
Shares
207,100
Price
$11.11
Total Value
$2.30M
Shares Held After
1,297,893
% of Holdings
16.0%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
1,000
Price
$2.65
Total Value
$2.65K
Shares Held After
106,465
% of Holdings
0.9%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
5,124
Price
$10.35
Total Value
$53.03K
Shares Held After
247,926
% of Holdings
2.0%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$5.67
Total Value
$45.36K
Shares Held After
62,405
% of Holdings
12.8%
PTC THERAPEUTICS, INC. (PTCT)
Okey Stephanie — Director
Shares
14,000
Price
$70.00
Total Value
$980.00K
Shares Held After
8,000
% of Holdings
63.6%
PTC THERAPEUTICS, INC. (PTCT)
Okey Stephanie — Director
Shares
1,167
Price
$70.00
Total Value
$81.69K
Shares Held After
8,000
% of Holdings
12.7%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
348
Price
$51.02
Total Value
$17.75K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
29,652
Price
$50.45
Total Value
$1.50M
Shares Held After
348
% of Holdings
98.8%
Stoke Therapeutics, Inc. (STOK)
Krainer Adrian R. — Director
Shares
33,243
Price
$39.74
Total Value
$1.32M
Shares Held After
283,302
% of Holdings
10.5%
Stoke Therapeutics, Inc. (STOK)
TZIANABOS ARTHUR — Director
Shares
4,355
Price
$40.00
Total Value
$174.21K
Shares Held After
31,339
% of Holdings
12.2%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
8,671
Price
$72.00
Total Value
$624.31K
Shares Held After
7,465
% of Holdings
53.7%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$22.12
Total Value
$22.12K
Shares Held After
37,415
% of Holdings
2.7%
Showing 401–450 of 1511 transactions (page 9 of 31)